Katie Tryhane
Stock Analyst at Credit Suisse
(1.31)
# 2,602
Out of 4,433 analysts
17
Total ratings
50%
Success rate
4.4%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Initiates: Outperform | $285 | $221.61 | +28.60% | 1 | Aug 25, 2022 | |
| AVTR Avantor | Maintains: Outperform | n/a | $24.99 | - | 1 | Sep 10, 2021 | |
| DHR Danaher | Maintains: Outperform | n/a | $265.80 | - | 1 | Sep 10, 2021 | |
| SOPH SOPHiA GENETICS | Initiates: Outperform | n/a | $4.54 | - | 1 | Aug 17, 2021 | |
| IDXX IDEXX Laboratories | Maintains: Outperform | n/a | $543.45 | - | 1 | Aug 13, 2021 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | n/a | $11.32 | - | 2 | Aug 11, 2021 | |
| FLGT Fulgent Genetics | Maintains: Underperform | n/a | $22.11 | - | 2 | Aug 10, 2021 | |
| ZTS Zoetis | Maintains: Outperform | n/a | $174.06 | - | 2 | Aug 9, 2021 | |
| NVST Envista Holdings | Maintains: Outperform | n/a | $18.53 | - | 2 | May 6, 2021 | |
| LNTH Lantheus Holdings | Maintains: Neutral | n/a | $79.67 | - | 1 | May 5, 2021 | |
| ALGN Align Technology | Maintains: Outperform | n/a | $271.50 | - | 1 | Oct 22, 2020 | |
| ICLR ICON PLC | Maintains: Outperform | n/a | $314.72 | - | 1 | Oct 22, 2020 | |
| TMO Thermo Fisher | Maintains: Neutral | n/a | $595.30 | - | 1 | Oct 22, 2020 |
Charles River Laboratories International
Aug 25, 2022
Initiates: Outperform
Price Target: $285
Current: $221.61
Upside: +28.60%
Avantor
Sep 10, 2021
Maintains: Outperform
Price Target: n/a
Current: $24.99
Upside: -
Danaher
Sep 10, 2021
Maintains: Outperform
Price Target: n/a
Current: $265.80
Upside: -
SOPHiA GENETICS
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.54
Upside: -
IDEXX Laboratories
Aug 13, 2021
Maintains: Outperform
Price Target: n/a
Current: $543.45
Upside: -
Maravai LifeSciences Holdings
Aug 11, 2021
Maintains: Outperform
Price Target: n/a
Current: $11.32
Upside: -
Fulgent Genetics
Aug 10, 2021
Maintains: Underperform
Price Target: n/a
Current: $22.11
Upside: -
Zoetis
Aug 9, 2021
Maintains: Outperform
Price Target: n/a
Current: $174.06
Upside: -
Envista Holdings
May 6, 2021
Maintains: Outperform
Price Target: n/a
Current: $18.53
Upside: -
Lantheus Holdings
May 5, 2021
Maintains: Neutral
Price Target: n/a
Current: $79.67
Upside: -
Align Technology
Oct 22, 2020
Maintains: Outperform
Price Target: n/a
Current: $271.50
Upside: -
ICON PLC
Oct 22, 2020
Maintains: Outperform
Price Target: n/a
Current: $314.72
Upside: -
Thermo Fisher
Oct 22, 2020
Maintains: Neutral
Price Target: n/a
Current: $595.30
Upside: -